BOTOX TOXTA 200

ToxTa 200 – High-Dose Botulinum Toxin for Advanced Aesthetic and Medical Applications

1. Overview & Manufacturer
ToxTa 200 is a botulinum toxin type A product developed by Jetema Co., Ltd., a respected South Korean pharmaceutical and medical aesthetics company. Known for its emphasis on purity, consistency, and clinical precision, ToxTa 200 is the high-dose version of the ToxTa line, crafted for practitioners needing a larger volume solution for multi-zone aesthetic treatments or therapeutic interventions.

2. Packaging & Composition

• Each vial contains 200 units of highly purified Clostridium botulinum toxin type A in lyophilized (freeze-dried) powder form.

• It must be reconstituted with sterile saline (0.9% NaCl) prior to use.

3. Mechanism of Action
ToxTa 200 works by blocking the release of acetylcholine at the neuromuscular junction. This temporary interruption of nerve signals to the muscle results in:

• Relaxation of overactive muscles

• Smoothing of dynamic facial wrinkles

• Reduction of glandular activity in areas such as the underarms (hyperhidrosis)

• Relief from conditions involving muscular tension or spasms

4. Key Advantages

• High-dose format (200U): Ideal for treating multiple facial areas, larger muscle groups, or high-volume therapeutic cases.

• Rapid onset: Visible effects may begin within 2–4 days of injection.

• Duration: Results typically last 3–6 months, depending on the treatment area and individual metabolic response.

• Highly purified formulation: Designed to reduce the risk of antibody formation, ensuring long-term effectiveness.

• Stable diffusion: Enables controlled, natural-looking results with minimal spread to adjacent tissues.

5. Clinical Applications

• Aesthetic Uses:

  • Full-face rejuvenation (forehead, glabella, crow’s feet)

  • Masseter muscle reduction (jawline slimming)

  • Chin and neck contouring

  • Trapezius and calf muscle slimming

• Therapeutic Uses:

  • Hyperhidrosis (excessive sweating)

  • Muscle spasticity (e.g., post-stroke or cerebral palsy)

  • TMJ tension or bruxism

  • Chronic migraine prevention (off-label)

6. Safety, Standards, and Approvals

• Approved by the Korean MFDS (Ministry of Food and Drug Safety)

• Produced under GMP-certified manufacturing processes

• Undergoing broader global adoption due to its reliable efficacy and competitive pricing

• Proven to be well-tolerated with a low incidence of adverse reactions when used appropriately

7. Storage & Administration

• Store between 2–8°C, protect from light

• Do not freeze

• Use reconstituted product within the timeframe specified by the manufacturer

• Must be administered by qualified, licensed medical professionals only